Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive COVID-19

Scientists discover troubling brain changes in COVID-19 patients who lost sense of smell

by Eric W. Dolan
September 25, 2024
in COVID-19, Neuroimaging
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

A new study published in Scientific Reports sheds light on long-term neurological consequences of COVID-19. Researchers found that individuals who had anosmia (the loss of smell) during COVID-19 showed alterations in brain functionality and even physical structure during recovery. This study is among the first to link COVID-19-related loss of smell to significant brain changes.

COVID-19, caused by the SARS-CoV-2 virus, has been primarily known for its impact on the respiratory system. However, over time, many patients, even those with mild cases, reported cognitive issues such as memory problems, confusion, and difficulties with concentration, which raised concerns about the virus’s effects on the brain. Neurological symptoms like headaches, brain fog, and loss of smell emerged as common issues for COVID-19 survivors.

Anosmia, the loss of smell, became one of the earliest and most recognizable symptoms of COVID-19, often occurring suddenly. While most patients recovered their sense of smell after a few weeks, some experienced longer-lasting olfactory dysfunctions. Previous research also suggested that loss of smell could signal broader neurological involvement in diseases like Alzheimer’s and Parkinson’s. Given the commonality of anosmia in COVID-19 and its potential implications for brain health, the researchers sought to explore whether loss of smell during COVID-19 was associated with any measurable brain changes in recovering patients.

“Our laboratory studies the neurobiological mechanisms underlying complex social behavior and decision-making. During the pandemic, it was very challenging to halt our experimental activities due to health restrictions,” said study author Pablo Billeke of the Center for Research in Social Complexity at the University for Development in Chile.

“In this context and given the early reports of neurological symptoms in patients affected by COVID-19, we wanted to contribute from our unique perspective to understanding the potential damage caused by SARS-CoV-2 infection in the central nervous system. This led us to initiate this study, in which we evaluated recovered COVID-19 patients using structural and functional magnetic resonance imaging while they performed decision-making and cognitive control tasks, as well as tracking their evolution with electroencephalography.”

To investigate these possible brain changes, the research team recruited 100 adults in Santiago, Chile, who had recovered from respiratory infections between February 2020 and May 2023. The final sample included 73 participants who had confirmed cases of COVID-19 (the remaining participants had respiratory infections caused by other agents, as confirmed by multiple negative PCR tests). The team used a combination of tests and brain scans across two sessions to assess these participants’ brain function and structure.

The participants ranged in age from 19 to 65, and none had severe cases of COVID-19 that required ventilators or intensive care. The study specifically excluded anyone with neuropsychiatric disorders or severe brain injuries, ensuring that the observed effects could be linked to their infection rather than prior conditions.

In behavioral tests, participants with a history of anosmia displayed more impulsive decision-making compared to those who did not lose their sense of smell. These individuals tended to change their choices more rapidly after receiving negative feedback, particularly in tasks requiring them to learn and adapt to changing probabilities of rewards. While this impulsivity led to higher earnings in decision-making tasks that involved rapidly shifting conditions, it also highlighted an alteration in how their brains processed rewards and risks.

Functionally, patients with a history of anosmia showed decreased brain activity during decision-making tasks in regions associated with evaluating choices, including the lateral prefrontal cortex and temporoparietal regions.

On the structural side, brain scans showed thinning in specific regions of the brain in participants with a history of anosmia. Most notably, these changes were observed in the parietal areas of the brain, which are responsible for processing sensory information and managing spatial awareness. The thinning in these areas could indicate long-term structural changes in the brain caused by the virus in individuals who experienced loss of smell.

Additionally, these participants exhibited decreased white matter integrity, particularly in white matter tracts that connect important brain regions. White matter plays a crucial role in facilitating communication between different parts of the brain, and disruptions in these connections could lead to a range of cognitive impairments.

“In the current context, where we know that a significant percentage of the population has contracted COVID-19 at some point, it is crucial to identify the factors that may make certain individuals more susceptible to developing brain alterations after infection,” Billeke told PsyPost. “Our study found that individuals who lost their sense of smell during the acute infection exhibited detectable changes in brain structure and showed a particular pattern in decision-making tasks involving learning.”

“Specifically, they made more impulsive decisions when the environmental context changed. While this may not necessarily have long-term consequences, it could serve as an early marker to monitor individuals who experienced loss of smell, helping to determine whether they are more susceptible to developing neurodegenerative alterations. This is particularly relevant when other risk factors, such as cardiovascular diseases, diabetes, and genetic predisposition, are present, all of which are linked to the development of neurodegenerative diseases.”

Interestingly, these brain changes were less pronounced in patients with more severe respiratory symptoms, such as those requiring hospitalization, suggesting that anosmia might be a more reliable indicator of neurological involvement than respiratory symptom severity.

“What surprised us the most was how consistent the findings were in patients with anosmia compared to other patients, regardless of the severity of their respiratory symptoms,” Billeke said. “These individuals exhibited detectable alterations at the behavioral level and in brain function and structure, affecting white matter and gray matter.”

While the study provides valuable insights, it has limitations. First, it relied on self-reported symptoms of anosmia and used the KOR test, a validated screening tool for olfactory deficits associated with COVID-19, to confirm the presence of olfactory dysfunction. More objective and comprehensive clinical assessments would provide stronger evidence.

Additionally, the study lacked baseline brain scans from before the participants contracted COVID-19. This makes “it difficult to establish a direct causal relationship between the infection and our findings,” Billeke explained. “However, when considered alongside the current body of evidence from other studies that have used databases or tracked individuals for different reasons, we can determine that the virus does indeed cause alterations at the neural level.”

“Thus, the correlations we found can be viewed in existing literature as potential evidence of a causal link between the virus and the observed effects. However, the exact mechanism by which the virus produces this damage at the brain level is still under investigation.”

Looking ahead, the researchers plan to follow up with these participants over time to see if the observed brain changes persist or if they affect daily life. They also aim to explore potential therapies, such as brain stimulation techniques, to help those experiencing lingering cognitive and neurological effects after COVID-19.

“We aim to identify the oscillatory patterns related to these alterations, which is the focus of our ongoing electroencephalography (EEG) studies,” Billeke said. “The data are currently being analyzed. By identifying these altered oscillatory patterns, we hope to develop brain stimulation therapies that could help alleviate these symptoms, such as transcranial electrical or magnetic stimulation.”

“I would like to extend my gratitude to all the participants who voluntarily came to the study for all their sessions and to all the researchers who worked tirelessly, especially during the most challenging times of the pandemic lockdown,” Billeke added.

The study, “Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations,” was authored by Leonie Kausel, Alejandra Figueroa-Vargas, Francisco Zamorano, Ximena Stecher, Mauricio Aspé-Sánchez, Patricio Carvajal-Paredes, Victor Márquez-Rodríguez, María Paz Martínez-Molina, Claudio Román, Patricio Soto-Fernández, Gabriela Valdebenito-Oyarzo, Carla Manterola, Reinaldo Uribe-San-Martín, Claudio Silva, Rodrigo Henríquez-Ch, Francisco Aboitiz, Rafael Polania, Pamela Guevara, Paula Muñoz-Venturelli, Patricia Soto-Icaza, and Pablo Billeke.

TweetSendScanShareSendPin17ShareShareShareShareShare

RELATED

Even mild cases of COVID-19 might result in brain shrinkage and impaired cognitive function
Neuroimaging

Neuroscientists detect decodable imagery signals in brains of people with aphantasia

July 6, 2025

Neuroscientists have found that people with aphantasia show distinct patterns of brain activity during imagery tasks, even without subjective visual experience. The study suggests that mental imagery and conscious visual awareness may rely on different neural mechanisms in the brain.

Read moreDetails
Stress disrupts gut and brain barriers by reducing key microbial metabolites, study finds
Mental Health

Stress disrupts gut and brain barriers by reducing key microbial metabolites, study finds

July 5, 2025

Researchers have shown that acute stress can disrupt gut microbial activity, lowering protective fatty acids that maintain intestinal and brain barrier integrity. The findings offer new insight into how short-term stress affects the body’s gut-brain communication system.

Read moreDetails
From fireflies to brain cells: Unraveling the complex web of synchrony in networks
Addiction

Understanding “neuronal ensembles” could revolutionize addiction treatment

July 3, 2025

The same brain system that rewards you for a delicious meal is hijacked by drugs like fentanyl. A behavioral neuroscientist explains how understanding the specific memories behind these rewards is the key to treating addiction without harming our essential survival instincts.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Mental Health

New brain stimulation method shows promise for treating mood, anxiety, and trauma disorders

July 2, 2025

Focused ultrasound targeting the amygdala safely reduced emotional brain reactivity and improved symptoms of depression, anxiety, and trauma disorders, suggesting it may be a promising new treatment for conditions that don’t respond to existing therapies.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Scientists uncover previously unknown target of alcohol in the brain: the TMEM132B-GABAA receptor complex
Dementia

Could creatine slow cognitive decline? Mouse study reveals promising effects on brain aging

July 1, 2025

A new study shows that creatine supplementation can restore memory, reduce brain damage, and boost energy metabolism in aging mice. The findings suggest creatine may offer a simple dietary approach to protect against age-related cognitive decline.

Read moreDetails
New psychology study sheds light on mysterious “feelings of presence” during isolation
COVID-19

Frequent dreams and nightmares surged worldwide during the COVID-19 pandemic

July 1, 2025

An international study of over 15,000 adults across 16 countries found that dream recall and nightmares became more common during the pandemic, with sleep duration, age, and gender all playing a role in how often people experienced them.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Being adopted doesn’t change how teens handle love and dating

Probiotics show promise for reducing hyperactivity in young children with autism and ADHD

Number of children affected by parental substance use has surged to 19 million, study finds

National narcissism linked to emotional impairments and dehumanization, new study finds

Personality may be a key factor connecting negative parenting experiences to adult challenges

New research reveals emotional control deficits in generalized anxiety disorder

People with higher cognitive ability have weaker moral foundations, new study finds

Positive attitudes toward AI linked to more prone to problematic social media use

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy